Medline Inc.

MDLN Healthcare Medical Instruments & Supplies

Medline Inc.’s revenue for fiscal 2025 (year ended December 2025) was $28.4 billion, up 11.5% from fiscal 2024.

Revenue
+14.1%
Free cash flow
+916.1%
Total debt
−23.7%

Quarter to September 2026, against a year earlier

39.96 0.39 −0.97%
Market cap
$52.3B
P/E
58.4×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
2.25
Beneish M
−2.38
Dividend safety
n/a

Medline Inc. (MDLN) EV/FCF

Alert me on EV/FCF

As of 5 November 2026, Medline Inc. (MDLN) trades at a EV/FCF of 14.5×. Over the past ten years it has ranged from 4.7× (December 2025) to 21.8× (April 2026); the current reading is higher than 39% of that period.

EV/FCF, daily

Embed this chart

Annual newest first

Period EV/FCF Change
FY2025 13.2× 183.12%
FY2024 4.7× 0.00%
FY2023 4.7× —

Quarterly newest first

Period EV/FCF Change
Sep 2026 13.0× (31.45%)
Jun 2026 19.0× (7.40%)
Mar 2026 20.5× 55.22%
Dec 2025 13.2× 183.12%
2 more quarters

Against its own ten years

Low 4.7× High 21.8×
Ten-year median 16.9×
Current reading's percentile 39

EV/FCF against peers

What EV/FCF is

EV/Free CF shows how the value of a whole company, debt included, compares with the free cash its business produces.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ (Operating Cash Flow (TTM) + Property, Plant, Equipment Change (Net) (TTM) + Intangible Assets Change (Net) (TTM))

The full definition of EV/FCF →

More on MDLN